Pharmaceutical composition comprising vanadium and/or salts...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/24 (2006.01)

Patent

CA 2318902

The present invention relates to the use of multivalent transition elements and/or salts thereof in a pharmaceutical composition to inhibit bacterial or yeast growth. Especially bacterial Pseudomonas growth is inhibited by using said pharmaceutical composition comprising vanadium and/or a salt thereof. Said vanadium or a vanadium salt is incorporated in a pharmaceutical composition as an essential element whereupon this pharmaceutical is applied for instance to burn-wound patients or patients having ulcers like diabetic foot ulcers.

L'invention porte sur l'utilisation d'éléments plurivalents de transition et/ou leurs sels dans une préparation pharmaceutique pour empêcher la croissance de bactéries ou de levures, et en particulier celle des bactéries Pseudomonas, lorsque la préparation comporte du vanadium ou l'un de ses sels. Ladite préparation dont le vanadium ou l'un de ses sels est un élément essentiel peut par exemple s'utiliser en application sur des brûlures ou des ulcères, tels que l'ulcère du pied du diabétique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition comprising vanadium and/or salts... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising vanadium and/or salts..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising vanadium and/or salts... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1786310

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.